⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EBS News
Emergent Biosolutions, Inc.
Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives
globenewswire.com
EBS
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
globenewswire.com
EBS
DUAL-PATHWAY BLOCKADE THERAPY OFFERS HOPE FOR RARE, HARD-TO-TREAT GYNAECOLOGICAL CLEAR CELL CANCERS
prnewswire.com
MRK
EBS
Form 8-K
sec.gov
EBS
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
globenewswire.com
EBS
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
globenewswire.com
EBS
Vivotif (Bavarian Nordic) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts 2020-2035
globenewswire.com
EBS
EBSCO Information Services To Release The New Yorker Magazine Archive
prnewswire.com
EBS
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
globenewswire.com
EBS
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
globenewswire.com
EBS